Usefulness  ||| S:0 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
NT-proBNP  ||| S:14 E:24 ||| JJ
as  ||| S:24 E:27 ||| IN
a  ||| S:27 E:29 ||| DT
heart  ||| S:29 E:35 ||| NN
disease  ||| S:35 E:43 ||| NN
marker  ||| S:43 E:50 ||| NN
for  ||| S:50 E:54 ||| IN
late-stage  ||| S:54 E:65 ||| JJ
elderly  ||| S:65 E:73 ||| JJ
patients  ||| S:73 E:82 ||| NNS
receiving  ||| S:82 E:92 ||| VBG
home  ||| S:92 E:97 ||| NN
medical  ||| S:97 E:105 ||| JJ
care  ||| S:105 E:110 ||| NN
The  ||| S:110 E:114 ||| DT
level  ||| S:114 E:120 ||| NN
of  ||| S:120 E:123 ||| IN
N-terminal  ||| S:123 E:134 ||| JJ
pro-brain  ||| S:134 E:144 ||| JJ
natriuretic  ||| S:144 E:156 ||| JJ
peptide ||| S:156 E:163 ||| NNS
( ||| S:163 E:164 ||| -LRB-
NT-proBNP ||| S:164 E:173 ||| NNP
) ||| S:173 E:174 ||| -RRB-
is  ||| S:174 E:177 ||| VBZ
a  ||| S:177 E:179 ||| DT
strong  ||| S:179 E:186 ||| JJ
predictor  ||| S:186 E:196 ||| NN
of  ||| S:196 E:199 ||| IN
mortality  ||| S:199 E:209 ||| NN
among  ||| S:209 E:215 ||| IN
patients  ||| S:215 E:224 ||| NNS
with  ||| S:224 E:229 ||| IN
coronary  ||| S:229 E:238 ||| JJ
heart  ||| S:238 E:244 ||| NN
disease ||| S:244 E:251 ||| NN
,  ||| S:251 E:253 ||| ,
and  ||| S:253 E:257 ||| CC
may  ||| S:257 E:261 ||| MD
be  ||| S:261 E:264 ||| VB
a  ||| S:264 E:266 ||| DT
strong  ||| S:266 E:273 ||| JJ
prognostic  ||| S:273 E:284 ||| JJ
marker  ||| S:284 E:291 ||| NN
for  ||| S:291 E:295 ||| IN
late-stage  ||| S:295 E:306 ||| JJ
elderly  ||| S:306 E:314 ||| JJ
patients  ||| S:314 E:323 ||| NNS
with  ||| S:323 E:328 ||| IN
heart  ||| S:328 E:334 ||| NN
disease  ||| S:334 E:342 ||| NN
receiving  ||| S:342 E:352 ||| VBG
home  ||| S:352 E:357 ||| NN
medical  ||| S:357 E:365 ||| JJ
care ||| S:365 E:369 ||| NN
.  ||| S:369 E:371 ||| .
We  ||| S:371 E:374 ||| PRP
assessed  ||| S:374 E:383 ||| VBD
the  ||| S:383 E:387 ||| DT
relationshipbetween  ||| S:387 E:407 ||| JJ
NT-proBNP  ||| S:407 E:417 ||| JJ
levels  ||| S:417 E:424 ||| NNS
and  ||| S:424 E:428 ||| CC
clinical  ||| S:428 E:437 ||| JJ
data  ||| S:437 E:442 ||| NNS
of  ||| S:442 E:445 ||| IN
240  ||| S:445 E:449 ||| CD
late-stage  ||| S:449 E:460 ||| JJ
elderly  ||| S:460 E:468 ||| JJ
patients  ||| S:468 E:477 ||| NNS
receiving  ||| S:477 E:487 ||| VBG
home  ||| S:487 E:492 ||| NN
medical  ||| S:492 E:500 ||| JJ
care  ||| S:500 E:505 ||| NN
in  ||| S:505 E:508 ||| IN
our  ||| S:508 E:512 ||| PRP$
clinic  ||| S:512 E:519 ||| NN
from  ||| S:519 E:524 ||| IN
May  ||| S:524 E:528 ||| NNP
2008  ||| S:528 E:533 ||| CD
to  ||| S:533 E:536 ||| TO
February  ||| S:536 E:545 ||| NNP
2011 ||| S:545 E:549 ||| CD
.  ||| S:549 E:551 ||| .
